Look for:

Our offer for

REGENERON PHARMACEUTICALS INC.


ISIN:
US75886F1075
WKN:
75886F107

2020/06/05 22:00:00
Price
597.00 USD
Difference -0.26% (-1.54)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)57,105 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)590.01 USD (100)
Ask (Ask size)596.00 USD (100)
Open585.00 USD
High600.14 USD
Low578.43 USD
Close (prev. day)598.54 USD
VWAP590.884368 USD
Volume (pcs)1,324,530
Trading volume782,399,658.41
Number of trades31,589
Last size94,128

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/06/05 22:00:00
Price
597.00 USD
Difference -0.26% (-1.54)

General attributes

ISINUS75886F1075
SymbolREGN
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)57,105 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)590.01 USD (100)
Ask (Ask size)596.00 USD (100)
Open585.00 USD
High600.14 USD
Low578.43 USD
Close (prev. day)598.54 USD
VWAP590.884368 USD
Volume (pcs)1,324,530
Trading volume782,399,658.41
Number of trades31,589
Last size94,128

Performance and Risk

6m1Y3Y
Perf (%)+62.08%+99.00%+24.31%
Perf (abs.)+228.66+297.00+116.74
Beta0.520.550.69
Volatility49.5540.1934.42
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)603.39 USD (1,360,563)
Ø price 30 days | Ø volume 30 days (pcs.)566.06 USD (1,730,770)
Ø price 100 days | Ø volume 100 days (pcs.)479.61 USD (1,440,674)
Ø price 250 days | Ø volume 250 days (pcs.)383.18 USD (1,028,063)
YTD High | date618.71 USD (2020/06/02)
YTD Low | date328.13 USD (2020/01/31)
52 Weeks High | date618.71 USD (2020/06/02)
52 Weeks Low | date271.37 USD (2019/09/27)

All listings for REGENERON PHARMACEUTICALS INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Vienna Stock Exchange2020/06/0517:32521.60 EUR0.0410
Tradegate2020/06/0522:26529.00 EUR0.2733
Stuttgart2020/06/0520:44525.80 EUR0.058
Nasdaq2020/06/0522:00597.00 USD782.4031,589
Munich2020/06/0518:55512.60 EUR0.113
London Stock Exchange2020/06/0416:31604.1408 USD0.027
Hamburg2020/06/0508:04525.20 EUR0.001
Frankfurt2020/06/0518:47515.00 EUR0.0310
Duesseldorf2020/06/0511:30531.70 EUR0.003
Berlin2020/06/0512:42536.80 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=99472&ID_TYPE_IMAGE_LOGO=2

Contact Details

REGENERON PHARMACEUTICALS INC.
- -
Old Saw Mill River Road 777 10591-6707 Tarrytown, New York
Telefon: +1-914-847-7000
Fax: -
E-mail: invest@regeneron.com

PDF Downloads

Company report: REGENERON PHARMACEUTICALS INC.PDF Download

Company Profile

Regeneron (NASDAQ: REGN) is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron commercializes medicines for high LDL cholesterol, eye diseases, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including oncology, rheumatoid arthritis, asthma, atopic dermatitis, pain, and infectious diseases.

Members of Management Board

P. Roy Vagelos, M.D.Chairman of Board of Directors
Tony Coles, M.D.Member of Board of Directors
Michael S. Brown, M.D.Member of Board of Directors
Joseph L. Goldstein, M.D.Member of Board of Directors
Huda Y. Zoghbi, M.D.Member of Board of Directors
George L. SingMember of Board of Directors
Christine A. PoonMember of Board of Directors
Arthur F. RyanMember of Board of Directors
Marc Tessier-LavigneMember of Board of Directors
Leonard S. SchleiferMember of Board of Directors
George D. YancopoulosMember of Board of Directors
Bonnie L. BasslerMember of Board of Directors
Leonard S. SchleiferChairman of Managing Board
Robert E. LandryMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer